Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4354925 | 0.83 | THRB (0.55) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL7815397 | 0.74 | LMNA (0.54) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL18871677 | 0.72 | HSD17B10 (0.43) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL3318902 | 0.70 | THRB (0.44) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL4878679 | 0.69 | CYP3A4 (0.32) | TSHR | |
| SCHEMBL4885878 | 0.69 | THRB (0.42) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL4882830 | 0.69 | THRB (0.42) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL4885696 | 0.69 | LMNA (0.44) | KMT2AALDH1A1HTTSMN1; SMN2LMNA | |
| SCHEMBL3313015 | 0.69 | THRB (0.42) | THRBKMT2AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL941531 | 0.69 | KMT2A (0.45) | THRBKMT2AALDH1A1HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817318-B1 | STABILIZING METHOD AND STABILIZED COMPOSITION FOR ARYL BORON COMPOUNDS | NIPPON CATALYTIC CHEM IND (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | NIPPON SHOKUBAI CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080154065-A1 | Stabilizing Method and Stabilized Composition for Aryl Boron Compounds | AR, AHR, BCL6 | THRB 2185/4885KMT2A 1263/4885ALDH1A1 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.